INM · ISSUER CIK 1728328
InMed Pharmaceuticals Inc.
Between Jul 31, 2026 and Oct 28, 2026, 1 InMed Pharmaceuticals Inc. insiders reported $204K of open-market purchases and $0.00 of sales on SEC Form 4. The largest buyer was ADAR1 Capital Management, LLC (10% Owner), with $204K.
↗1 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. No open-market sales in the window.
$204KInsider buying
$0.00Insider selling
+$204KNet open-market
Oct 27, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 27, 202614:13 | Oct 23, 2026 | INM | 10% Owner · +1 joint | P · Buy | $1.32 | +4 | 956,584 | +0% | +$5.28 | -21.0% | +21.1% |
| Oct 20, 202617:31 | Oct 19, 2026from Oct 16, 2026 | INM | 10% Owner · +1 joint | P · Buy | $1.32 | +1,087 | 956,580 | +0% | +$1K | -28.6% | +21.1% |
| Oct 15, 202616:39 | Oct 15, 2026from Oct 13, 2026 | INM | 10% Owner · +1 joint | P · Buy | $1.33 | +9,569 | 955,493 | +1% | +$13K | -28.1% | +20.3% |
| Oct 8, 202618:27 | Oct 8, 2026from Oct 6, 2026 | INM | 10% Owner · +1 joint | P · Buy | $1.33 | +10,903 | 945,924 | +1% | +$14K | -28.2% | +20.4% |
| Oct 5, 202617:11 | Oct 5, 2026from Oct 1, 2026 | INM | 10% Owner · +1 joint | P · Buy | $1.33 | +42,920 | 935,021 | +5% | +$57K | -28.1% | +20.2% |
| Sep 16, 202618:58 | Sep 16, 2026from Sep 14, 2026 | INM | 10% Owner · +1 joint | P · Buy | $1.30 | +91,101 | 892,101 | +11% | +$118K | -29.9% | +23.4% |